Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes

Diabetes Care

Volumn 36, Issue 11, 2013, Pages 3436-3441

  Engwerda, Elsemiek E C ^a   Tack, Cees J ^a   De Galan, Bastiaan E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN ASPART; METFORMIN; PLACEBO; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; SHORT ACTING INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE SAFETY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG DELIVERY DEVICE; DRUG DOSE REDUCTION; EVENING DOSAGE; FEMALE; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PEN; JET INJECTION; JET INJECTOR; MALE; MEAL; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; AGED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; INSULIN INFUSION; NEEDLE; POSTPRANDIAL STATE; YOUNG ADULT;

ADULT; AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, JET; INSULIN ASPART; INSULIN INFUSION SYSTEMS; INSULIN, SHORT-ACTING; MALE; MIDDLE AGED; NEEDLES; POSTPRANDIAL PERIOD; YOUNG ADULT;

EID: 84891877473     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0492     Document Type: Article

References (27)

1. Monnier L, Colette C, Owens D. Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts. Diabetes Technol Ther 2011;13(Suppl. 1): S25-S32
2. Siebenhofer A, Plank J, Berghold A, et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. CochraneDatabase Syst Rev 2006; 19:CD003287
3. Rassam AG, Zeise TM, Burge MR, Schade DS. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes. Diabetes Care 1999;22:133-136
4. Peyrot M, Rubin RR, Kruger DF, Travis LB. Correlates of insulin injection omission. Diabetes Care 2010;33:240-245
5. Gale EA. Two cheers for inhaled insulin. Lancet 2001;357:324-325
6. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997; 20:585-590
7. Aronson R. The role of comfort and discomfort in insulin therapy. Diabetes Technol Ther 2012;14:741-747
8. Malone JI, Lowitt S, Grove NP, Shah SC. Comparison of insulin levels after injection by jet stream and disposable insulin syringe. Diabetes Care 1986;9:637-640
9. Mitragotri S. Current status and future prospects of needle-free liquid jet injectors. Nat Rev Drug Discov 2006;5:543-548
10. Engwerda EE, Abbink EJ, Tack CJ, de Galan BE. Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology. Diabetes Care 2011;34:1804-1808
11. Abumrad NN, Rabin D, Diamond MP, LacyWW. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism 1981;30:936-940
12. de Galan BE, Tack CJ, Lenders JW, et al. Theophylline improves hypoglycemia unawareness in type 1 diabetes. Diabetes 2002;51:790-796
13. de Galan BE, Engwerda EE, Abbink EJ, Tack CJ. Body mass index and the efficacy of needle-free jet injection for the administration of rapid-acting insulin analogs, a post hoc analysis. Diabetes Obes Metab 2013;15:84-86
14. Radermecker RP, Renard E, Scheen AJ. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control. Diabetes Metab Res Rev 2009;25:491-501
15. Vora JP, Burch A, Peters JR, Owens DR. Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care 1992;15:1484-1493
16. McQuaid SE, Humphreys SM, Hodson L, Fielding BA, Karpe F, Frayn KN. Femoral adipose tissue may accumulate the fat that has been recycled as VLDL and nonesterified fatty acids. Diabetes 2010;59: 2465-2473
17. Hildebrandt P. Skinfold thickness, local subcutaneous blood flow and insulin absorption in diabetic patients. Acta Physiol Scand Suppl 1991;603:41-45
18. Vora JP, Burch A, Peters JR, Owens DR. Absorption of radiolabelled soluble insulin in type 1 (insulin-dependent) diabetes: influence of subcutaneous blood flow and anthropometry. Diabet Med 1993;10:736-743
19. Tobin L, Simonsen L, Bulow J. The dynamics of the microcirculation in the subcutaneous adipose tissue is impaired in the postprandial state in type 2 diabetes. Clin Physiol Funct Imaging 2011;31:458-463
20. Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabetes Obes Metab 2012;9999:1081-1087
21. Schramm J, Mitragotri S. Transdermal drug delivery by jet injectors: energetics of jet formation and penetration. Pharm Res 2002;19:1673-1679
22. Stachowiak JC, Li TH, Arora A, Mitragotri S, Fletcher DA. Dynamic control of needlefree jet injection. J Control Release 2009; 135:104-112
23. Schramm-Baxter J, Mitragotri S. Needlefree jet injections: dependence of jet penetration and dispersion in the skin on jet power. J Control Release 2004;97:527-535
24. Linn L, Boyd B, Iontchev H, King T, Farr SJ. The effects of system parameters on in vivo injection performance of a needlefree injector in human volunteers. Pharm Res 2007;24:1501-1507
25. Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Clin Ther 2009;31:980-987
26. Muchmore DB, Vaughn DE. Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations. J Diabetes Sci Tech 2010;4:419-428
27. Steiner S, Hompesch M, Pohl R, et al. A novel insulin formulation with a more rapid onset of action. Diabetologia 2008; 51:1602-1606